ORX:STO
Orexo AB
SEKÂ 1.37
arrow_downward
-1.58%(-0.022) 1D
Nov 6, 5:29:49 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 1.47
High
SEKÂ 1.47
Low
SEKÂ 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 1.30
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 1.47
High
SEKÂ 1.47
Low
SEKÂ 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEKÂ 36.00
52-wk low
SEKÂ 1.30
EPS
SEKÂ 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
The Motley Fool
·
3 hours ago
This Dividend King Yielding 2X the S&P 500 Looks Like a Buy in November.
FXEmpire
·
1 hour ago
S&P 500 Price Forecast: Strong Jobs Data Tests Rebound After AI Rout
BBN Times
·
7 hours ago
DJIA Falls to 51,285.73 as Rate-Hike Fears Hit Blue Chips Amid US-Iran Tensions and Rising Treasury Yields
Investing.com
·
7 hours ago
Poland’s Domanski blames presidential vetoes as S&P cuts outlook to negative
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com